Request Your Free Infographic Now:

"Tech Transfers: 5 CDMO Strategies to Speed Time to Market"

This infographic explores pharma tech transfer strategies to CDMOs, highlighting challenges, timelines, and best practices for quicker market entry.

In the pharmaceutical industry, technology transfers are critical but challenging. With the global CDMO market for topical drugs expected to exceed $368 billion by 2034, and large biopharma companies managing over 100 tech transfers simultaneously, the stakes are high. Most tech transfers take 18-30 months, with organizational complexities, regulatory differences, and process inconsistencies creating bottlenecks.

This infographic reveals five strategic approaches for optimizing late-stage tech transfers to CDMOs, improving outcomes and accelerating time to market. By examining what pharmaceutical companies need from manufacturing partners, it provides a roadmap for addressing common pain points that delay development and launches.

• Discover why over 50% of commercial and clinical trial manufacturing for oral solid dosage forms is outsourced
• Learn the top seven tech transfer pain points costing time and money
• Explore five essential CDMO attributes for successful transfers

Offered Free by: BioPharma Dive's studioID and Thermo Fisher Scientific
See All Resources from: BioPharma Dive's studioID and Thermo Fisher Scientific